Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 20 of 20 entries
View as:

Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain

Phase: N/A Priority: Normal
NCT ID: NCT02716857 Org: User:
Start: 03/31/16 End: 11/30/17 Due: 11/30/18

Study to Assess the PK of Ketorolac Tromethamine Intranasal and to Assess the Effects of a Oxymetazoline Hydrochloride on the PK of Ketorolac Tromethamine

Phase: N/A Priority: Normal
NCT ID: NCT01363089 Org: User:
Start: 01/31/07 End: 02/29/08 Due: 02/28/09

Single Dose Pharmacokinetics of Egalet® Hydrocodone

Phase: N/A Priority: Normal
NCT ID: NCT00802087 Org: User:
Start: 11/30/08 End: 04/30/09 Due: 04/30/10

Safety and Efficacy of Multiple Doses of Ketorolac Tromethamine Administered Intranasally for Postoperative Pain

Phase: N/A Priority: Normal
NCT ID: NCT01347853 Org: User:
Start: 06/30/03 End: 06/30/07 Due: 06/30/08

Tolerability, Safety and Pharmacokinetics of Four Formulations of Ketorolac Tromethamine in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01355588 Org: User:
Start: 08/31/05 End: 03/31/06 Due: 03/31/07

Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain

Phase: N/A Priority: Normal
NCT ID: NCT02603705 Org: User:
Start: 03/07/16 End: 06/15/17 Due: 06/15/18

A Efficacy and Safety Trial of Controlled Release (CR) Morphine in Cancer Patients

Phase: N/A Priority: Normal
NCT ID: NCT00446069 Org: User:
Start: 08/31/07 End: 08/31/08 Due: 08/31/09

Study to Determine the Tolerability, Safety and Pharmacokinetics of Ketorolac Tromethamine by Intranasal Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01363050 Org: User:
Start: 01/31/06 End: 09/30/06 Due: 09/30/07

A Study of Controlled-Release Carvedilol Compared to Immediate-Release Carvedilol in Patients With Primary Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00444834 Org: User:
Start: 04/30/07 End: 05/31/07 Due: 05/31/08

Study to Assess the Absorption and Tolerability of Intranasal Ketorolac Tromethamine and to Assess the Effects of Oxymetazoline Hydrochloride and Fluticasone Propionate on the Absorption and Tolerability of Intranasal Ketorolac Tromethamine in Participants With Allergic Rhinitis

Phase: N/A Priority: Normal
NCT ID: NCT01365650 Org: User:
Start: 12/31/07 End: 06/30/08 Due: 06/30/09

Study of the Tolerability of Ketorolac Tromethamine Following Intranasal Administration in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT01363063 Org: User:
Start: 12/31/06 End: 06/30/07 Due: 06/30/08

Efficacy and Safety of Intranasal Ketorolac for the Acute Treatment of Migraine

Phase: N/A Priority: Normal
NCT ID: NCT00483717 Org: User:
Start: 07/31/07 End: 01/31/08 Due: 01/31/09

Effects of a Single Dose of Egalet® Morphine Combined With a Single Dose of Alcohol in Healthy Moderate Drinkers

Phase: N/A Priority: Normal
NCT ID: NCT00802308 Org: User:
Start: 12/31/08 End: 02/28/09 Due: 02/28/10

A Single-dose Study of Intranasal Ketorolac in the Treatment of Pain Secondary to Dental Impaction Surgery

Phase: N/A Priority: Normal
NCT ID: NCT01356225 Org: User:
Start: 02/29/04 End: - Due: -

Assessment of Nasal Deposition and Clearance of Ketorolac Solution Administered Using the Valois Nasal Spray Device

Phase: N/A Priority: Normal
NCT ID: NCT01356212 Org: User:
Start: 09/30/02 End: 12/31/02 Due: 12/31/03

Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00266786 Org: User:
Start: 12/31/05 End: - Due: -

Open Label Study to Assess the Pharmacokinetics of Intranasal Ketorolac Tromethamine Following Fluticasone Propionate in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01365611 Org: User:
Start: 02/28/07 End: 03/31/08 Due: 03/31/09

The Pharmacokinetics of Ketorolac Tromethamine Administered Intranasally (IN) for Postoperative Pain in Children Aged 12 Through 17 Years

Phase: N/A Priority: Normal
NCT ID: NCT01363076 Org: User:
Start: 06/30/07 End: 05/31/08 Due: 05/31/09

SPRIX in 0 to 11 Year-Old Patients Undergoing Open Surgical Procedures

Phase: N/A Priority: Normal
NCT ID: NCT02102516 Org: User:
Start: 03/31/14 End: 07/31/15 Due: 07/31/16

Single Dose Pharmacokinetics of Egalet® Oxycodone

Phase: N/A Priority: Normal
NCT ID: NCT00801788 Org: User:
Start: 09/30/08 End: 02/28/09 Due: 02/28/10